Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human CLCN1 ELISA Kit (AC3709)
Cat.#: ASET-2298
Specifications
Description Human CLCN1 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human CLCN1 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.095 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 2.5-40 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1900 Human Drebrin ELISA Kit (AC3311) Quantitative inquiry ASET-1481 Human Laminin alpha 1 ELISA Kit (AC2892) Quantitative inquiry ASET-2283 Human Vimentin ELISA Kit (AC3694) Quantitative inquiry ASET-1872 Human 5HT1A Receptor ELISA Kit (AC3283) Quantitative inquiry ASET-1869 Human Nogo ELISA Kit (AC3280) Quantitative inquiry ASET-1066 Human UNC5B ELISA Kit (AC2477) Quantitative inquiry ASET-1007 Human MT3 ELISA Kit (AC2418) Quantitative inquiry ASET-2208 Human Homer1 ELISA Kit (AC3619) Quantitative inquiry ASET-2458 Human Meteorin ELISA Kit (AC3869) Quantitative inquiry ASET-1367 Porcine Syndecan-1 ELISA Kit (AC2778) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket